Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Neoplasms 3Colorectal Neoplasms 3Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Sarcoma 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Lymphangioleiomyomatosis 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gliosarcoma 1Glioblastoma 1Colonic Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms, Male 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 25Bevacizumab 18Paclitaxel 17Pemetrexed 16Erlotinib Hydrochloride 14Radiotherapy 12Docetaxel 9Gemcitabine 7Cisplatin 6ceritinib 5Taxes 5Cetuximab 5pembrolizumab 3pegfilgrastim 3capmatinib 3Surgical Procedures, Operative 3Radiosurgery 3Metformin 3Gefitinib 3Cyclophosphamide 3Thalidomide 2Sorafenib 2Radiotherapy, Conformal 2Nivolumab 2Immunoglobulin G 2Filgrastim 2Disulfides 2Albumin-Bound Paclitaxel 25-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma of Lung × Hydroxychloroquine × Clear all
NCT00728845 2017-05-23

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Terminated
8 enrolled 6 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡